15997-62-3

Usage

Uses

Used in Flavor and Fragrance Industry:
ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is used as a flavor and fragrance ingredient for its sweet, fruity scent, enhancing the aroma of various products.
Used in Perfume Production:
In the perfume industry, ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is used as a component in creating complex and appealing fragrances, contributing to the overall scent profile.
Used in Soap and Personal Care Products:
ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is used in the production of soaps and other personal care products to provide a pleasant scent and enhance the sensory experience for consumers.
Used as a Solvent in Industrial Processes:
This chemical compound can also serve as a solvent in various industrial applications, facilitating chemical reactions and processes that require a solvent medium.
Used as a Plasticizer in Polymer Production:
ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is utilized as a plasticizer in the production of polymers, helping to increase the flexibility and workability of the materials.
It is crucial to handle ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER with care due to its potential hazards if not properly managed, ensuring safety in its applications across different industries.

InChI:InChI=1/C7H6O5/c1-4(8)11-5-2-6(9)12-7(10)3-5/h2H,3H2,1H3

Upstream product

• 542-05-2 acetonedicarboxylic acid 
• 108-24-7 acetic anhydride 

Downstream Products

• 1155419-89-8 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid 
• 1402714-51-5 methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate 
• 1402714-51-5 methyl 2-(tert-butoxy)-2-((S)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate 
• 1155419-89-8 BI-224436 
• 1402714-51-5 C₂₈H₂₈N₂O₄ 
• 1155270-72-6 7-bromo-2,3-dihydropyrano[4,3,2-de]quinoline 
• 1155270-71-5 7-bromo-5-chloro-2,3-dihydropyrano[4,3,2-de]quinoline 
• 1155270-69-1 8-bromo-5-hydroxy-4-(2-hydroxyethyl)quinolin-2(1H)-one 
• 1155270-66-8 C₁₄H₁₄BrNO₆ 
• 189003-92-7 Trelanserin 
• 21298-80-6 2-(2-oxo-1,2-dihydroquinoline-4-yl)acetic acid 
• 214045-56-4 3-(acetyloxy)-5-[(3-fluorophenyl)amino]-5-oxopent-2-enoic acid 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR

The present invention is directed to an improved process for the preparation of Compounds of Formula (I) or salts thereof which are useful in the treatment of HIV infection. In particular, the present invention is directed to an improved process for the preparation of (2S)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)- 2-methylquinolin-3-yl)acetic acid or salt thereof which is useful in the treatment of HIV infection. R4 is selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n) and (o); and R6 and R7 are each independently selected from H, halo and (C1-6) alkyl.

THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS

The present invention relates to a series of compounds of formula (A) having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula I : wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.